iShares Biotechnology ETF (NASDAQ:IBB) Stock Position Reduced by Advisory Services Network LLC

Advisory Services Network LLC decreased its stake in iShares Biotechnology ETF (NASDAQ:IBBGet Rating) by 18.1% during the 1st quarter, HoldingsChannel reports. The firm owned 12,716 shares of the financial services provider’s stock after selling 2,808 shares during the period. Advisory Services Network LLC’s holdings in iShares Biotechnology ETF were worth $1,657,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. UBS Group AG increased its position in shares of iShares Biotechnology ETF by 10.9% during the 1st quarter. UBS Group AG now owns 2,005,796 shares of the financial services provider’s stock valued at $261,355,000 after purchasing an additional 196,343 shares during the period. Citigroup Inc. boosted its position in iShares Biotechnology ETF by 23.6% during the first quarter. Citigroup Inc. now owns 1,973,585 shares of the financial services provider’s stock valued at $257,158,000 after purchasing an additional 376,498 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of iShares Biotechnology ETF by 49.9% in the first quarter. Goldman Sachs Group Inc. now owns 1,568,159 shares of the financial services provider’s stock worth $204,332,000 after buying an additional 521,820 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of iShares Biotechnology ETF by 29.5% in the first quarter. JPMorgan Chase & Co. now owns 626,866 shares of the financial services provider’s stock worth $81,680,000 after purchasing an additional 142,937 shares during the period. Finally, Commerce Bank increased its stake in shares of iShares Biotechnology ETF by 0.9% in the fourth quarter. Commerce Bank now owns 583,506 shares of the financial services provider’s stock worth $89,055,000 after purchasing an additional 5,127 shares during the period. Institutional investors own 60.42% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $122.96 on Monday. iShares Biotechnology ETF has a 12-month low of $104.29 and a 12-month high of $174.45. The stock’s 50-day moving average price is $125.52 and its 200 day moving average price is $122.49.

About iShares Biotechnology ETF

(Get Rating)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Articles

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBGet Rating).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.